89bio, Inc. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported net loss was USD 28.84 million compared to USD 25.57 million a year ago. Basic loss per share from continuing operations was USD 0.54 compared to USD 1.26 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.92 USD | +0.25% | -2.70% | -29.10% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-29.10% | 779M | |
+15.55% | 121B | |
+12.66% | 107B | |
-2.53% | 24.82B | |
+1.14% | 22.48B | |
-9.35% | 18.32B | |
-42.28% | 16.33B | |
-18.92% | 15.31B | |
+6.19% | 14.08B | |
+28.83% | 11.74B |
- Stock Market
- Equities
- ETNB Stock
- News 89bio, Inc.
- 89bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023